Prof. Tom Webster Appointed Editor-in-Chief of Journal of Nanomedicine

Professor Tom Webster has just received notification that he has been appointed the Editor-in-Chief for the Journal of Nanomedicine.

The Journal of Nanomedicine is an international, peer-reviewed publication focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. Reflecting the growing activity in this emerging specialty, the aim of this journal is to highlight research and development leading to potential clinical applications in the prevention and treatment of disease.

Subject areas will include:

  • Application of nanotechnology in the diagnosis, prevention, and treatment of disease
  • Diagnostic tools, analytical techniques, including biochips, microarrays, biosensors, molecular sensors, nanoprobes, nanoscale genomic and proteomic research, and nanoimaging
  • Nanodevices and nanomaterials, including nanotubes, fullerenes, biomedical microsystems, device miniaturization, cellular and tissue engineering, nano bioresponsive systems (diagnostic and drug delivery devices)
  • Nanodrug complexes and drug delivery systems including polymer therapeutics (eg, pegylated proteins, polymer drug conjugates, polymeric drugs) for improved drug, protein, or gene transport and targeting
  • Specific focus on development and clinical use from the perspectives of safety, efficacy, economics, and ultimate patient uptake.

    Additional information on the Journal of Nanomedicine can be found at http://www.dovepress.com/IJN.htm